Figure 3From: Analysis of the clinical relevance of antimitochondrial antibodies to the β- and γ-subunits of the F1F0-ATPase in patients with primary biliary cirrhosis Influence of UDCA therapy on reactivity of anti-β (a) and –γ−antibodies (b). Only patients being positive for the respective subunits before therapy are included. Individual values at the three time points are given. - = median.Back to article page